Practical Example of a Split Benefit Accelerated Critical Illness Insurance Product

Similar documents
Multiple Critical Illness Benefits from market needs to product solutions

MODELLING CRITICAL ILLNESS INSURANCE DATA

Critical Illness Presentation

All you need to know

Information Guide Booklet. Life Insurance

Critical Illness Fit for the Elderly?

Product Summary. Life s better with the right partner. Life Cover. November Complimentary Final Family Expenses. Why consider Life Cover?

Preliminary Report on. Hong Kong Assured Lives Mortality and Critical Illness. Experience Study

Content. Christian Cypris SCOR Global Life SE, R&D Centre Karsten de Braaf SCOR Global Life SE, Asia Pacific, Product Development 07/05/2013

A CRITICAL TABLE: PRICING CRITICAL ILLNESS IN THE UK ON A NEW INSURED LIVES TABLE

Product Disclosure Statement Version 11, Issued 21 May Life s better with the right partner AIA.COM.AU. Priority Protection

Zurich Life Risk Trauma cover

2015 Star Ratings. Critical Illness Cover. Discussion paper

Priority Protection for Platform Investors

QoL Performer Plus SM. Life Insurance + Optionality = Opportunities that Can Last a Lifetime!

Birla Sun Life Insurance Platinum Advantage Plan. Birla Sun Life Insurance Company Limited

Staff Paper. IASB Meeting Agenda reference 4C. Deposit floor for Insurance Contracts

How much insurance cover?

Professional Insurance Portfolio

The Baltimore Life Insurance Company

Heriot-Watt University. M.Sc. in Actuarial Science. Life Insurance Mathematics I. Tutorial 5

Z Protect. Because your greatest treasures deserve the most protection

The real value of protection. Our life, critical illness and income protection claims

The real value of protection. Our life, critical illness and income protection claims

INVESTMENT SAVINGS & INSURANCE ASSOCIATION OF NZ INC ISI QUARTERLY STATISTICS GUIDELINE FOR COMPLETING RETURNS

Both types of policies can accumulate substantial savings. The earlier you start, the more you could earn from the policy by the time you retire.

Foresters Lifefirst Non-Medical Term Insurance

How To Get A Life Insurance Policy

FutureWise at a glance. Macquarie Life

How To Get A Life Insurance Policy With Alpha Insurance

BT Protection Plans. Product Disclosure Statement and Policy Document (PDS)

KEY FEATURES OF THE MORTGAGE REVIEW PLAN. Important information you need to read

Key Features and Terms and Conditions of Family Life Insurance

Westpac Protection Plans

Priority Protection for Platform Investors

Simplified Issue Term

Industry Critical Illness Survey. Eddie McEllin Senior Actuary Tel eddie.mcellin@genre.com

The Primary Representative for Indiana Manufacturers before the Indiana General Assembly

Whole of life. It is never too early...

Priority Protection. Product Disclosure Statement Version 13, Date Prepared 1 March Life s better with the right partner

What is Secure Joint Life Plan?

43,303,919 paid out in critical illness claims in the first six months of 2012*

Please read this document carefully as it contains important information about this plan. Your VitalityLife plan summary VITALITYLIFE PLAN SUMMARY

Zurich Life Risk Zurich Protection Plus

52,929,390 paid out in critical illness claims in the first six months of 2013*

AGENTS GUIDE TO SELLING THIS PRODUCT

Birla Sun Life Insurance Riders. Birla Sun Life Insurance Company Limited

Advisor Sales Guide. insurenow insurenow Plus. Fast. Flexible. Forward thinking. FOR ADVISOR USE ONLY

Life Living Assurance Customer guide LIVING ASSURANCE. TotalCareMax Customer guide. Life. Take charge. sovereign.co.nz

Home Certainty Policy Specs

Critical Illness insurance AC04 diagnosis rates

Multiple Choice Questions. 1 In which of the following circumstances would a term life policy be paid out prior to the death of the insured?

Retail insurance through the Annex IOOF Pursuit platform

Genetic Testing, Insurance Underwriting and Adverse Selection

Critical Illness Insurance International Overview What can we learn from highly developed CI markets?

Protecting Your Assets and Lifestyle: A Critical Illness Insurance Review

International Term Assurance

How To Rate A Life Insurance Policy

Trendsetter. LB Series. Product Overview

Assurity Life s Critical Illness Insurance. USBI# A (Rev. 12/13)

ANZ Chief Investment Office. Leo Mauceri Insurance Research Manager. William Burkitt Global Head of Investment Product & Research

CRITICAL ILLNESS TRENDS

Key Features of the Term Assurance Plan

REAL Trauma Cover. What is it?

SBI Life Insurance Company Limited

Singapore Insured Lives

CommInsure Protection

Lifetime Annuity and Scheme Pension Key Features

Personal Insurance. Do I need Trauma cover? a safety. to help get you back on track

Permanent Life Insurance. 100% Pure Protection

Life Insurance You Don t Have to Die to Use. Policies issued by American General Life Insurance Company (AGL).

Individual insurance transfer

Peace. Mind. VivoLife. Why is it good for me? Flexible payment terms. A lifetime of protection. 4 enhanced protection 1 (up to 350% of sum assured)

Zurich Wealth Protection. Product Disclosure Statement including Policy conditions Issue date: 1 March 2012

Critical Illness Rider for Individual Insurance Wendy Lee, FSA, MAAA. Abstract

CRITICAL ILLNESS INSURANCE

Priority Protection. Product Disclosure Statement Version 15, Date Prepared 21 November Life s better with the right partner

Long-Term Care (LTC) Riders

Foresters Lifefirst Producer Guide

Direct Insurance Who, what and why? Comparison of direct and retail products and strategies

We give you invaluable peace of mind at an affordable price. The Power of We. Essential protection for you and your loved ones AIA.COM.

Life insurance and TPD cover. Protect their tomorrows

INSTITUTE AND FACULTY OF ACTUARIES EXAMINATION

Transcription:

Practical Example of a Split Accelerated Critical Illness Insurance Product Anton Brink, Ph.D. RGA UK Services Limited

Presentation Disclaimers: Contains all personal views based on external research These views are not representative of RGA or its clients Methodology utilises illustrative examples Not meant to be used as a prescriptive guide on how to price Buy-Back CI 2

Overview of Presentation CI Limitations & Available Buy-Back Products PMI Data to determine Option Premium for a Multi-State Buy-Back Model Determine Buy-Back Option Premium for a Restricted set of CI Conditions Results for Buy-Back Option Premiums Conclusions & Further Work 3

Critical Illness Conditions Cancer Cardiovascular Neurological Other 4

Main Limitation of CI Only a single claim is payable with CI product Reinstatement of CI benefit is then very expensive as claimant perceived to be at a higher risk of further CI claim incidences or earlier death Avoided if a buy-back option had been purchased at the initial policy inception for a small additional premium 5

Buy-Back Available in Australia 100% of the amount of any claim will be reinstated with no further medical evidence one year from the date your claim was accepted. The same condition or connected (e.g. stroke after heart attack) is excluded Particular conditions are excluded, e.g. T.I., T.P.D. Need to select option initially at additional premium Zurich - Stepped annual reinstatement to full benefit Maximum purchase age 60, buy-back ceases at age 70 6

or Cover Reinstatement in the U.K. But only certain conditions can be reinstated E.g. Scottish Provident: Heart attack, Stroke and Cancer Limit of reinstatement % of S.A. or 100,000 The cost of the buy-back is around 10% of premium Other considerations: Guaranteed/Reviewable Premium Rates Full, reduction or Waiver of subsequent Premiums We have not included any restrictions in our analysis 7

Overview of Presentation CI Limitations & Available Buy-Back Products PMI Data to determine Option Premium for a Multi-State Buy-Back Model Determine Buy-Back Option Premium for a Restricted set of CI Conditions Results for Buy-Back Option Premiums Conclusions & Further Work 8

Data Problems Once a policyholder makes a valid 1 st claim, the CI coverage ceases So no insured CI data available to determine a 2 nd CI incidence rate Utilise instead Private Medical Insurance (PMI) or Medical Expenses settled claimant data, where repeat claims are recorded 9

PMI Data for Buy-Back Model Our Female Data of 1 st, 2 nd PMI Claims 10

Problems with PMI Data Amounts too small & frequent compared to large & infrequent CI claims Claims are not pre-assigned into different incidents Need to assume a time-break (of say 180 days) between claims to signify separate incidents Different type of claim definition, policyholder profile, underwriting approach etc. With these problems in mind, build a model 11

Standard Life Model D: Death M H: Healthy W: Withdrawal Transition from State H to D Payable M 12

Accelerated Critical Illness (ACI) HD: Death with no incidents M H: Healthy M A: Post 1 st Qualifying HW: Withdrawal with no incidents Transition from State H to D H to A Payable M M 13

Partial ACI Model HD: Death with no incidents M H: Healthy AD: Death Post 1 st Qualifying M b M (1-b ) A: Post 1 st Qualifying AW: Withdrawal Post 1 st Qualifying HW: Withdrawal with no incidents b Model 100% Standard ACI % Life Reinstatement 0% Standard Life Transition from State H to D H to A Payable M M x b A to D M x (1- b) 14

General Buy-Back Model HD: Death with no incidents M H: Healthy AD: Death Post 1 st Qualifying Mxb M (1-b ) A: Post 1 st Qualifying AW: Withdrawal Post 1 st Qualifying Mx(1-b) BD: Death Post 2 nd Qualifying B: Post 2 nd Qualifying HW: Withdrawal with no incidents BW: Withdrawal Post 2 nd Non- Qualifying b All Condition CI Model 100% Standard ACI % Full 100% buy-back 0% Our Delayed Transition from State H to D H to A Payable M M x b A to B, A to D M x (1- b) 15

Methodology Probabilities For each of the main condition groups Paid claim counts developed to obtain expected diagnosed claims Found fitted 1 st incidence rates by graduating the developed claim counts from state H to state A exposure in state H Similarly, 2 nd incidence rates from state A to state B, death & withdrawal incidence rates Corresponding probabilities found using formula for Kolmogorov forward differential equations 16

Methodology Profit Margin (PM) For a particular choice of main condition group Probabilities used to build a profit cash flow model Expected Profit = expected premiums - expected benefits - change in expected reserves for each year of policy term Chose summary statistic to compare models Profit margin (PM) = Total discounted expected profit Total discounted expected premium Found premium corresponding to a 20% profit margin (before expenses, commissions, tax etc.) Rescaled premium in order that a 40 year old female with a standard ACI only product would pay 100 17

20 30 40 60 0% (Impaired) 100% (ACI) 25% 20 75% % (Buy-Back) 30 40 60 Relative Premium Relative Premium General Buy-Back Model Relative Premium for 20% Profit Margin for Selected Buy-Back % s with Increasing Age 275 2 225 200 175 1 125 100 75 Relative Premium Required for a 20% Profit Margin for Increasing Age 0% (Impaired) 25% % (Buy-Back) 75% 100% (ACI) Relative Premium Required for a 20% Profit Margin 275 2 225 200 175 1 125 100 75 25 0 Age 25 0 % b Age 18

0% (Impaired) 100% (ACI) 25% 20 75% % (Buy-Back) 30 40 60 Relative Premium Relative Premium General Buy-Back Model Relative Premium for 20% Profit Margin for Selected Ages with Increasing Buy-Back % s 275 Relative Premium Required for a 20% Profit Margin for Increasing % of Premium Payable on 1st Relative Premium Required for a 20% Profit Margin 2 2 225 200 175 1 20 30 40 60 225 200 175 1 125 100 75 125 100 25 0 75 Age 25 0 0% (Impaired) 25% % (Buy-Back) 75% 100% (ACI) Age % b 19

% (Buy-Back) 25% 0% (Impaired) 100% (ACI) 20 75% 30 40 60 Relative Premium General Buy-Back Model Relative Premium Required for a 20% Profit Margin 275 2 225 200 175 1 125 100 75 25 0 Age % b 20

% (Buy-Back) 25% 0% (Impaired) 100% (ACI) 20 75% 30 40 60 Relative Premium General Buy-Back Model 2-275 225-2 200-225 175-200 1-175 125-1 100-125 75-100 -75 25-0-25 Relative Premium Required for a 20% Profit Margin 275 2 225 200 175 1 125 100 75 25 0 Age % b 21

% (Buy-Back) 25% 0% (Impaired) 100% (ACI) 20 75% 30 40 60 Relative Premium General Buy-Back Model 2-275 225-2 200-225 175-200 1-175 125-1 100-125 75-100 -75 25-0-25 Relative Premium Required for a 20% Profit Margin 275 2 225 200 175 1 125 100 75 25 0 Age % b 22

% (Buy-Back) 25% 0% (Impaired) 100% (ACI) 20 75% 30 40 60 Relative Premium General Buy-Back Model 2-275 225-2 200-225 175-200 1-175 125-1 100-125 75-100 -75 25-0-25 Relative Premium Required for a 20% Profit Margin 100% 40 275 2 225 200 175 1 125 100 75 25 0 Age % b 23

% (Buy-Back) 25% 0% (Impaired) 100% (ACI) 20 75% 30 40 60 Relative Premium General Buy-Back Model 20% PM 2-275 225-2 200-225 175-200 1-175 125-1 100-125 75-100 -75 25-0-25 Relative Premium Required for a 20% Profit Margin 100% 57 47 40 275 2 225 200 175 1 125 100 75 25 0 Age % b 24

% (Buy-Back) 25% 0% (Impaired) 100% (ACI) 20 75% 30 40 60 Relative Premium General Buy-Back Model 20% PM 2-275 225-2 200-225 175-200 1-175 125-1 100-125 75-100 -75 25-0-25 Relative Premium Required for a 20% Profit Margin 100% 100 100 47 40 275 2 225 200 175 1 125 100 75 25 0 Age % b 25

Relative Premium Required for 20% Profit Margin Buy-Back Option Premium 1 400 3 300 2 Relative Premium Required for 20% Profit Margin Stand-Alone All Conditions Accelerated All Conditions Buy-Back All Conditions Buy - back option premium 1 Death 200 1 100-20 30 40 60 Age Notes: Premium option equal to buy-back premium less standard premium Relative to a 40 year old female with a standard ACI product costing 100 26

Overview of Presentation CI Limitations & Available Buy-Back Products PMI Data to determine Option Premium for a Multi-State Buy-Back Model Determine Buy-Back Option Premium for a Restricted set of CI Conditions Results for Buy-Back Option Premiums Conclusions & Further Work 27

New Restricted Model CI cover expensive for an unhealthy life By unhealthy mean previous medical history of a minor non-ci complaint, e.g. slight angina Considered at a higher risk of claiming for a related CI condition, e.g. any cardiovascular Offer a restricted product which provides coverage for the remaining unrelated CI conditions 28

Basic Restricted Model Basic Solution: Only model the restricted CI conditions Ignore the other conditions related to the poor health Split our post 1st incident state into two parts a qualifying state A for those conditions with a benefit payment a non-qualifying state A other for the remaining nonbenefit conditions 29

Basic Restricted Model HD: Death with no incidents M H: Healthy AD: Death Post 1 st Qualifying M b Mx(1-b ) A: Post 1 st Qualifying AW: Withdrawal Post 1 st Qualifying Model Basic Restricted b 100% HW: Withdrawal with no incidents M A Other D: Death Post 1 st Non- Qualifying A Other : Post 1 st Non-Qualifying A Other W: Withdrawal Post 1 st Non- Qualifying Transition from State H to D, A other to D H to A Payable M M x b A to D M x (1- b) 30

Problem with Basic Model However, basic model ignores non-qualifying conditions Unhealthy life may contract one of the nonqualifying conditions as an intermediate step, before satisfying one of the qualifying conditions If the incidence from a non-qualifying condition to a qualifying condition is higher than from the healthy state, then the basic model underestimates the required premium 31

Standard Restricted Model Include non-qualifying conditions To include the above we need to allow a further transition from the non-qualifying state A other to say a qualifying state B Where State B has the same conditions as the qualifying state A 32

Standard Restricted Model HD: Death with no incidents M H: Healthy HW: Withdrawal with no incidents AD: Death Post 1 st Qualifying M b M (1-b ) M A Other D: Death Post 1 st Non- Qualifying A: Post 1 st Qualifying A Other : Post 1 st Non-Qualifying AW: Withdrawal Post 1 st Qualifying M A Other W: Withdrawal Post 1 st Non- Qualifying BD: Death Post 2 nd Qualifying B: Post 2 nd Qualifying BW: Withdrawal Post 2 nd Non- Qualifying Transition from State H to D, A other to D, A other to B H to A Model Standard Restricted b 100% Payable M M x b A to D M x (1- b) 33

Example for Individual Conditions It may appear appealing to find premiums for our grouped main condition models: cancer only model, cardiovascular only model, neurological only model. However, we cannot add the premiums together from a menu of such grouped condition models in order to determine the premium for a model with a tailored set of grouped conditions In particular, the premiums do not sum to the premium for an All Conditions model 34

Premium for Standard Restricted Models Relative Premium for a 20% Profit Margin in each Individual Condition for the "Simplified" ACI Model 60 Age 40 30 All Neurological All Cardiovascular All Malignant Cancer All CI 20 0% % 100% 1% 200% 2% 300% Relative Premium for a 20% Profit Signature 35

General Restricted Buy-Back Model HD: Death with no incidents M H: Healthy HW: Withdrawal with no incidents AD: Death Post 1 st Qualifying Mxb M (1-b ) M A Other D: Death Post 1 st Non- Qualifying A: Post 1 st Qualifying A Other : Post 1 st Non-Qualifying AW: Withdrawal Post 1 st Qualifying Mx(1-b) M A Other W: Withdrawal Post 1 st Non- Qualifying BD: Death Post 2 nd Qualifying B: Post 2 nd Qualifying BW: Withdrawal Post 2 nd Non- Qualifying Transition from State H to D, A other to D, A other to B H to A Model Buy Back Restricted b % Payable M M x b A to B, A to D M x (1- b) 36

Relative Accelerated Cancer Premium Premium for Cancer Conditions 400 3 300 2 200 Relative Accelerated Cancer Only Premium for a 20% Profit Margin Buy-Back Restricted Cancer Standard Cancer Basic Cancer buy-back option Premium 2 intermediary nonqualifying conditions 1 100 0 20 30 40 60 Age Notes: Premiums for full benefit payment M on 1 st incident Relative to a 40 year old female with a standard cancer only product costing 100 37

General Restricted Buy-Back Model Can also exclude certain parts of a CI condition e.g. as an extreme case, breast cancer from our previous female cancer only product 38

Relative Accelerated Cancer Premium Premium for Cancer (ex breast) 400 3 300 Relative Accelerated Cancer Only Premium for a 20% Profit Margin Buy-Back Restricted Cancer Buy-Back Restricted Cancer (ex breast) Standard Cancer Decrease in premium on excluding breast cancer 2 200 Basic Cancer 1 100 0 20 30 40 60 Age 39

Relative Accelerated Cancer Premium Premium for Cancer (ex breast) 400 3 300 2 Relative Accelerated Cancer Only Premium for a 20% Profit Margin Buy-Back Restricted Cancer Buy-Back Restricted Cancer (ex breast) Standard Cancer Standard Cancer (ex breast) Basic Cancer buy-back option Premium 3 200 1 100 0 20 30 40 60 Age 40

Relative Accelerated Cancer Premium Premium for Cancer (ex breast) 400 3 Relative Accelerated Cancer Only Premium for a 20% Profit Margin Buy-Back Restricted Cancer (ex breast) 300 2 200 1 Standard Cancer (ex breast) Basic Cancer (ex breast) buy-back option Premium 3 intermediary nonqualifying conditions 100 0 20 30 40 60 Age 41

Overview of Presentation CI Limitations & Available Buy-Back Products PMI Data to determine Option Premium for a Multi-State Buy-Back Model Determine Buy-Back Option Premium for a Restricted set of CI Conditions Results for Buy-Back Option Premiums Conclusions & Further Work 42

Relative Option Premium Required for a 20% Profit Margin Buy-Back Option Premiums 1 to 3 140 120 Relative Buy-Back Option Premium Required for a 20% Profit Margin Buy-Back Buy-Back Margin Option All Premium Conditions1 All Conditions Buy-Back Option Cancer Premium 2 Cancer 100 Buy-Back Buy-Back Option Option Cancer Premium (ex Breast) 3 Cancer (ex Breast) 80 60 40 20 0 20 30 40 60 Age Notes: Premium option equal to buy-back premium less Standard premium Relative to a 40 year old female with a standard Cancer only product costing 100 43

Overview of Presentation CI Limitations & Available Buy-Back Products PMI Data to determine Option Premium for a Multi-State Buy-Back Model Determine Buy-Back Option Premium for a Restricted set of CI Conditions Results for Buy-Back Option Premium Conclusions & Further Work 44

Conclusions Presented multi-state models To determine the buy-back premium, while Allowing any non-qualifying conditions to act as an intermediary state before a qualifying condition Found different buy-back premium curves by age when we have all the conditions, a restriction to cancer only or cancer only, but excluding breast cancer 45

Conclusions The buy-back premium option curves indicate An increase of 30% at age 20 to 55% at age 60 in the non buy-back model premium This fairly high cost of the buy-back option premium is likely to result from including small multiple claims data Introducing restrictions to the buy-back option would reduce the premium 46

Further Work Further analysis of the PMI database to better match the data to typical CI incidence rates Determining the size of reductions to the buy-back premium on applying the restrictions discussed in the introduction Further details in the corresponding paper at www.ica2010.com Any Questions? 47

Contact Details Anton Brink RGA UK Services Limited 16th Floor, 5 Aldermanbury Square, London, EC2V 7HR T +44207 710 6831 abrink@rgare.com 48